GCN1L1, also known as GCN1, is implicated in a series of critical cellular processes, especially in protein synthesis under stress conditions. The protein's role in these pathways gives rise to a plethora of potential indirect activators that can modulate its function through various cellular signals. Chemicals such as Forskolin and Isoproterenol, both of which target the cAMP pathways, are examples of compounds that can indirectly influence the cellular contexts in which GCN1L1 operates. Lithium chloride, an activator of the Wnt signaling pathway, may also provide an environment conducive to the function of GCN1L1 in cells.
Similarly, the MAPK/ERK pathway, which can be modulated by U0126 and PD98059, both MEK inhibitors, may intersect with GCN1L1's functionalities. LY294002 and Wortmannin, known PI3K inhibitors, suggest a connection between the PI3K/AKT pathway and GCN1L1, highlighting its wide-reaching relevance in cellular dynamics. Rapamycin, an mTOR inhibitor, underscores the importance of GCN1L1 in cellular growth and protein synthesis pathways, and the potential influence this compound can have on the protein's role. PMA, which activates Protein Kinase C, further demonstrates the expansive cellular signaling network that GCN1L1 might be associated with.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, which can influence GCN1L1 activity through related signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Can activate the Wnt signaling pathway, which may be relevant to the GCN1L1 function in cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can modulate the MAPK/ERK pathway, potentially impacting GCN1L1's role. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
CDK inhibitor affecting cell cycle processes, which might be relevant to GCN1L1's functions. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
A calcium ionophore; can elevate intracellular calcium levels, potentially influencing pathways linked with GCN1L1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; its modulation of the PI3K/AKT pathway may be related to GCN1L1's cellular activities. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC); can influence pathways where GCN1L1 is involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; affects cellular growth and protein synthesis pathways that can be relevant to GCN1L1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor; its effect on cytoskeletal dynamics can intersect with pathways where GCN1L1 operates. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
β-adrenergic receptor agonist; can modulate cAMP pathways, potentially influencing GCN1L1. | ||||||